Welcoming our new CTO
Genetic Signatures is thrilled to welcome our new Chief Technology Officer, Susanne Pedersen, Ph.D.
Susanne Pedersen holds a Ph.D. in Molecular Biology and brings over 25 years of experience in oncology and molecular diagnostics. With 13 years leading clinical trial studies from concept to completion, she has a proven track record in building and managing high-performance R&D and clinical teams. As a co-founder and Vice President of Science & Innovation at Clinical Genomics Pty, Susanne was instrumental in the discovery, validation, and commercialization of COLVERA, Australia’s first CLIA-accredited liquid biopsy test for colorectal cancer. Her expertise spans R&D leadership, international clinical trial management, quality assurance, regulatory affairs, and the successful interface between clinical research, production, marketing, and sales.
Welcome Susanne!
|
Our team of diagnostics experts are available to help you support laboratory planning. |
Join our network to keep apprised of relevant news.
   |
|
Was this article helpful? Be the first to receive updates like this. |
For enquiries related to this article, please contact [email protected]